Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Quantum Biopharma (QNTM) Shares Outstanding (Weighted Average) (2018 - 2025)

Quantum Biopharma's Shares Outstanding (Weighted Average) history spans 8 years, with the latest figure at $169551.0 billion for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 112794335.9% to $169551.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $169551.0 billion, a 112794335.9% increase, with the full-year FY2025 number at $35.4 million, down 76.45% from a year prior.
  • Shares Outstanding (Weighted Average) hit $169551.0 billion in Q4 2025 for Quantum Biopharma, up from $3801.2 billion in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for QNTM hit a ceiling of $169551.0 billion in Q4 2025 and a floor of $49613.0 in Q4 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $19143.2 billion across 5 years, with a median of $610.0 billion in 2024.
  • The widest YoY moves for Shares Outstanding (Weighted Average): up 10686094515.38% in 2024, down 98.43% in 2024.
  • Tracing QNTM's Shares Outstanding (Weighted Average) over 5 years: stood at $49613.0 in 2021, then soared by 288958.43% to $143.4 million in 2022, then decreased by 3.93% to $137.8 million in 2023, then increased by 9.1% to $150.3 million in 2024, then skyrocketed by 112794335.9% to $169551.0 billion in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for QNTM at $169551.0 billion in Q4 2025, $3801.2 billion in Q3 2025, and $3021.0 billion in Q2 2025.